🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchAnyone else refreshing ClinicalTrials.gov every morning or just me Page 5

Anyone else refreshing ClinicalTrials.gov every morning or just me

TrialNerd_Beth Thu, Apr 30, 2026 at 8:30 AM 22 replies 944 viewsPage 5 of 5
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
May 8, 2026 at 9:19 PM#21
pete_nash said:
That is right, and it stops being right at the edges.

Second this. I had assumed I was the exception until I read this.

Last edited: May 9, 2026 at 1:19 AM
29 4steve_okc, dave_SLC, FDA_TrackerJim and 26 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
May 11, 2026 at 6:08 PM#22
pete_nash said:
That is right, and it stops being right at the edges.

There is a second half to this that has not been said yet. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

28 3raj_cambridge, ingrid_STO, pete_nash and 25 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
May 14, 2026 at 2:59 PM#23

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

27 2DataDave, Dr.GutHealth, amsterdam_pete and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
May 17, 2026 at 11:52 AM#24

One thing that is still open after pete_nash’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: May 17, 2026 at 4:52 PM
26 1julia.endo, JessicaM_2024, TomFromTexas and 23 others
Reply Quote Save Share Report
patPC_UT
Member
212
890
Nov 2024
Park City, UT
May 20, 2026 at 8:46 AM#25
PharmacoVig_BOS said:
Practical: whatever you change, write down the date and the reason.

This is where I part company with the consensus forming above. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Last edited: May 20, 2026 at 1:46 PM
25 0julia.endo, JessicaM_2024, TomFromTexas and 22 others
Reply Quote Save Share Report
1345

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register